Healthy Subjects, Overactive Bladder
1 clinical trials · Condition
◉ Watch Healthy Subjects, Overactive Bladder
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male Subjects (NCT02938507) | Velicept Therapeutics, Inc. | 2016-10-01 |
Track Healthy Subjects, Overactive Bladder automatically
Every clearance here is in the API, with alerts when new ones post.